Plain-English translation of NCT06696027 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
The AYLo study is investigating whether specific genetic changes that occur in blood cells — particularly the loss of the Y chromosome in some blood cells — play a role in autoimmune and rheumatologic diseases like rheumatoid arthritis, vasculitis, and sarcoidosis. Researchers will analyze blood samples using advanced genetic and immune profiling techniques to understand how these changes might influence disease development and progression. The goal is to discover whether these genetic markers could help doctors better predict disease course and personalize treatment in the future.
Doctors don't yet fully understand why some people develop autoimmune diseases while others don't, or why the disease affects different people in different ways. This study aims to fill that gap by exploring whether genetic changes in blood cells contribute to autoimmune disease, which could eventually lead to better ways to predict who will develop these diseases and how to treat them more effectively.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic where doctors will take a blood sample and collect information about your medical history and current health. If you are newly diagnosed, you would be asked to return for a follow-up visit about one year later for another blood sample and health update. The blood samples will be analyzed using advanced genetic and immune testing techniques to look for patterns in how genetic changes relate to your disease.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Germany